Stock Yards Bank & Trust Company decreased its stake in Celgene Co. (NASDAQ:CELG) by 14.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The hedge fund owned 117,497 shares of the biopharmaceutical company’s stock after selling 19,072 shares during the period. Celgene accounts for about 2.0% […]
